comparemela.com

Latest Breaking News On - Samuel barone - Page 1 : comparemela.com

Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress

/PRNewswire/ Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today.

Dallas
Texas
United-states
Gainesville
Florida
University-of-south-florida
Maryland
Fort-lauderdale
Baltimore
Peter-kaiser
Christine-kay
Samuel-barone

Nanoscope Therapeutics Announces Presentations at the ARVO Annual Meeting

/PRNewswire/ Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today.

Dallas
Texas
United-states
Subrata-batabyal
Najam-sharif
Vinitb-mahajan
Samarendra-mohanty
Samuel-barone
Nanoscope-therapeutics-inc
Prnewswire-nanoscope-therapeutics-inc
Professor-of-ophthalmology-at-stanford-university
Seattle-convention-center

Gene therapy improves vision in patients with retinitis pigmentosa in phase 2b trial

Gene therapy improves vision in patients with retinitis pigmentosa in phase 2b trial
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Samuel-barone

Nanoscope Therapeutics Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2023

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced presentations at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting and Eyecelerator @ AAO 2023 taking place in San Francisco, California. Details for the presentations are as follows:

Samuel-barone
Francisco-marriott-marquis
Moscone-center
Nanoscope-therapeutics-inc
Session-title
San-francisco-marriott-marquis
Nob-hill
Chief-medical
Multi-characteristic-opsin
Late-breaking-developments
Live-broadcast
West-building

Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer

/PRNewswire/ Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, announced today.

California
United-states
San-diego
India
Australia
Dallas
Texas
New-york
Samuel-barone
Psulagna-bhattacharya
Office-of-cellular
Prnewswire-nanoscope-therapeutics-inc

vimarsana © 2020. All Rights Reserved.